Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery

Biomaterials
Tian-Meng SunJun Wang

Abstract

A novel amphiphilic and cationic triblock copolymer consisting of monomethoxy poly(ethylene glycol), poly(epsilon-caprolactone) (PCL) and poly(2-aminoethyl ethylene phosphate) denoted as mPEG(45)-b-PCL(100)-b-PPEEA(12) was designed and synthesized for siRNA delivery. The copolymers were well characterized by (1)H NMR spectroscopy and gel permeation chromatography. Micelle nanoparticles' (MNPs) formation of this amphiphilic copolymer in aqueous solution was studied by dynamic light scattering, transmission electron microscopy and fluorescence technique. MNPs took uniform spherical morphology with zeta potential of around 45 mV and were stabilized by hydrophobic-hydrophobic interaction in the PCL core, exhibiting the critical micelle concentration at 2.7 x 10(-3) mg/mL. Such MNPs allowed siRNA loading post nanoparticle formation without change in uniformity. The average diameter of nanoparticles after siRNA binding ranged from 98 to 125 nm depending on N/P ratios. The siRNA loaded nanoparticles can be effectively internalized and subsequently release siRNA in HEK293 cells, resulting in significant gene knockdown activities, which was demonstrated by delivering two siRNAs targeting green fluorescence protein (GFP). It effectively ...Continue Reading

References

Mar 17, 2001·Advanced Drug Delivery Reviews·K KataokaY Nagasaki
May 17, 2001·Bioconjugate Chemistry· Han SoS W Kim
Mar 12, 2003·Advanced Drug Delivery Reviews·Hidenori OtsukaKazunori Kataoka
Apr 23, 2003·Advanced Drug Delivery Reviews·Zhong ZhaoKam W Leong
Apr 26, 2003·Science·Radoslav SavicDusica Maysinger
Oct 8, 2004·Organic Letters·Deepak M ShendageGünter Haufe
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
Dec 29, 2004·Journal of Drug Targeting·Serguei V VinogradovAlexander V Kabanov
May 4, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sun Hwa KimTae Gwan Park
May 24, 2005·Nature Biotechnology·Erwei SongJudy Lieberman
Jul 26, 2005·Nature Biotechnology·David V MorrisseyBarry Polisky
Aug 30, 2005·Biomaterials·Qiang LiKam W Leong
Mar 28, 2006·Nature·Tracy S ZimmermannIan MacLachlan
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Nov 17, 2006·Biomaterials·Chookaet WachiralarpphaithoonKazunari Akiyoshi
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Jan 16, 2007·Biomaterials·Ji Hoon JeongSung Wan Kim
Feb 27, 2007·Nature Medicine·Zdravka MedarovaAnna Moore
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dan PeerMotomu Shimaoka
Jun 2, 2007·Nature Reviews. Drug Discovery·Antonin de FougerollesJudy Lieberman
Jun 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xu-Li WangZheng-Rong Lu
Jun 23, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ayumi SatoAtsushi Maruyama
Oct 10, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shyh-Dar LiLeaf Huang
Dec 18, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shyh-Dar LiLeaf Huang
Jul 26, 2008·Nature Nanotechnology·Yan GengDennis E Discher

❮ Previous
Next ❯

Citations

Dec 3, 2010·Nanoscale Research Letters·Min ZhangShi-Wen Huang
Apr 4, 2009·Bioconjugate Chemistry·William H BlackburnL Andrew Lyon
Sep 15, 2010·Molecular Pharmaceutics·Weiwei GaoOmid C Farokhzad
Oct 20, 2010·International Journal of Molecular Sciences·Heidi M MansourPatrick P Deluca
Feb 6, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cheng-Qiong MaoJun Wang
Nov 15, 2012·Future Oncology·Pengxiao Cao, Younsoo Bae
Sep 26, 2013·Pharmaceutical Research·Ruijun XingXiaoyuan Chen
Oct 25, 2014·Nanomedicine·Jun ZhaoMarites P Melancon
Mar 7, 2013·Molecular Pharmaceutics·Eun Jung ChoYoon Yeo
Jul 5, 2012·Journal of Drug Targeting·Zong-Wei WuShu-Yi Lin
Jun 19, 2013·Journal of Colloid and Interface Science·Dong MaLi-Ming Zhang
Apr 9, 2013·Journal of Colloid and Interface Science·Hossein Rezvantalab, Shahab Shojaei-Zadeh
Dec 26, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hong-Xia WangJun Wang
Jul 6, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shuang DouJun Wang
Apr 25, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Thomas EndresThomas Kissel
Jan 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ruogu QiXiabin Jing
Aug 3, 2011·Neurochemistry International·Garima SrivastavaMahendra Pratap Singh
Dec 25, 2010·Biomaterials·Olivia M MerkelThomas H Kissel
Dec 16, 2010·Advanced Drug Delivery Reviews·Feng Li, Ram I Mahato
Feb 4, 2010·Biomaterials·Min Suk Shim, Young Jik Kwon
Dec 26, 2009·Biomaterials·Sheng-Dong XiongPaul K Chu
Aug 12, 2009·International Journal of Pharmaceutics·XiaWei WeiZhiYong Qian
Aug 5, 2009·Biomaterials·David F Williams
Jul 2, 2009·The Journal of Gene Medicine·Eun-Joong KimChang-Koo Shim
Jul 28, 2011·Macromolecular Bioscience·Sarah M SparksKathryn E Uhrich
Jan 10, 2013·Macromolecular Bioscience·Xuan DongXuesi Chen
Oct 19, 2011·Macromolecular Bioscience·Mehrdad HamidiKobra Rostamizadeh
May 1, 2013·Small·Huayu TianXuesi Chen
Mar 25, 2011·Advanced Materials·José A BarretoLeone Spiccia
Nov 20, 2009·Macromolecular Bioscience·Yu-Cai WangJun Wang
Oct 9, 2014·Angewandte Chemie·Tianmeng SunYounan Xia
Feb 24, 2015·Angewandte Chemie·Lu ZhangXingyu Jiang
Feb 9, 2013·IEEE Transactions on Bio-medical Engineering·Ying Hsu, Andreas A Linninger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.